{"DataElement":{"publicId":"7125100","version":"1","preferredName":"Tissue Slide Greater Than or Equal To Twenty Percent Tumor Cell Nuclei Eligible Histologic Type Indicator","preferredDefinition":"A yes/no response to indicate whether a tumor segment slide meet the acceptance criteria of necrosis ≤20%, total cellularity ≥50%, tumor nuclei ≥20%.","longName":"7120717v1.0:3506068v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7120717","version":"1","preferredName":"Tissue Slide Greater Than or Equal To Twenty Percent Tumor Cell Nuclei Eligible Histologic Type","preferredDefinition":"A slide on which a tissue section has been mounted._A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways._A natural number greater than nineteen and less than twenty-one and the quantity that it denotes._A quantitative measurement of the percent of tumor cell nuclei in a sample compared to the total number of nuclei in the sample._Satisfying the appropriate conditions for inclusion._Refers to the type of tissue in which a tumor originated.","longName":"7125053v1.0:7120715v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7125053","version":"1","preferredName":"Tissue Slide","preferredDefinition":"A slide on which a tissue section has been mounted.","longName":"C165223","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue Slide","conceptCode":"C165223","definition":"A slide on which a tissue section has been mounted.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9BA468D7-E634-5EC7-E053-F662850AB138","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-08","modifiedBy":"ONEDATA","dateModified":"2020-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7120715","version":"1","preferredName":"Greater Than or Equal To Twenty Percent Tumor Cell Nuclei Eligible Histologic Type","preferredDefinition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.:A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.:A quantitative measurement of the percent of tumor cell nuclei in a sample compared to the total number of nuclei in the sample.:Satisfying the appropriate conditions for inclusion.:Refers to the type of tissue in which a tumor originated.","longName":"7120715v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater Than or Equal To","conceptCode":"C61583","definition":"A statement about the relative size or order of two objects specifying that either both objects are the same in quantity or measure or value or status or that the object of interest exceeds the other object in one of these ways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Twenty","conceptCode":"C105799","definition":"A natural number greater than nineteen and less than twenty-one and the quantity that it denotes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Percent Tumor Cell Nuclei","conceptCode":"C165615","definition":"A quantitative measurement of the percent of tumor cell nuclei in a sample compared to the total number of nuclei in the sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Eligible","conceptCode":"C126586","definition":"Satisfying the appropriate conditions for inclusion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9B7DFAA3-BE11-7C45-E053-F662850AE1BF","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"ONEDATA","dateModified":"2020-01-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9B7DFAA3-BE22-7C45-E053-F662850AE1BF","latestVersionIndicator":"Yes","beginDate":"2020-01-06","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-06","modifiedBy":"KNABLEJ","dateModified":"2020-02-13","changeDescription":"1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/6/20 jk created for CPTAC Path Review CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3506068","version":"1","preferredName":"Yes No Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes/no.","longName":"YES_NO_IND","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No","valueDescription":"No","ValueMeaning":{"publicId":"3197154","version":"1","preferredName":"No","longName":"3197154","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-55AD-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":"2022.12.28 Alt VM added per ticket request CADSR0001837. aj","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75C2-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"},{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"3197153","version":"1","preferredName":"Yes","longName":"3197153v1.00","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D865DE5-558A-1AC9-E040-BB89AD436B4F","latestVersionIndicator":"Yes","beginDate":"2011-03-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2011-03-02","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C37A1BEB-75CC-B6C9-E040-BB89AD434179","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"ONEDATA","dateModified":"2012-06-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"3502157","version":"1","preferredName":"Yes No Indicator Value Domains","preferredDefinition":"Conceptual domain that includes value meanings to be used for Indicator Value Meanings such as Yes, No, Unknown, No Applicable","longName":"YES_NO_IND_VD","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C377DE0C-8C3E-DCA8-E040-BB89AD431B6D","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CURTIST","dateCreated":"2012-06-27","modifiedBy":"CURTIST","dateModified":"2012-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2421125","version":"1","preferredName":"Ind-2","preferredDefinition":"A caDSR representation term that is used to indicate a question with permissible values of yes/no","longName":"C38147","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes or No Response","conceptCode":"C38147","definition":"A response or indicator that can have a value of either yes or no.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RETIRED ARCHIVED","registrationStatus":"Retired","id":"0303DF01-F4B4-15EC-E044-0003BA3F9857","latestVersionIndicator":"No","beginDate":"2005-10-18","endDate":"2016-04-27","createdBy":"SHIDED","dateCreated":"2005-10-18","modifiedBy":"TAYLORT","dateModified":"2020-10-03","changeDescription":"10.3.20 TL changed WFS from RETIRED PHASED OUT to RETIRED ARCHIVED. Changed Workflow Status DBW 04-27-2016","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C37A1BEB-75AE-B6C9-E040-BB89AD434179","latestVersionIndicator":"Yes","beginDate":"2012-06-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2012-06-27","modifiedBy":"TSESU","dateModified":"2023-08-16","changeDescription":"8/29/17 tt added CSI per Round 5 finalization task. 3/12/17 jk added Standard reg status; ownership transfered from CTEP to NCI Standards with concurrence of CTEP/Brian Campbell. jk","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"5635376","version":"1","longName":"Prostate","context":"OCCPR"},{"publicId":"6779562","version":"1","longName":"PRAD Local Pathology","context":"OCCPR"},{"publicId":"6779563","version":"1","longName":"PRAD Pathology Review","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"This slide meets required acc","type":"Preferred Question Text","description":"This slide meets required acceptance criteria (histologic type eligible, necrosis ≤20%, total cellularity ≥50%, tumor nuclei ≥20%)","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9BA4B420-A5CC-60B7-E053-F662850AE25F","latestVersionIndicator":"Yes","beginDate":"2020-01-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-08","modifiedBy":"KNABLEJ","dateModified":"2021-07-12","changeDescription":"7/12/21 jk added HNSCC Path Rpt CSI in error. 2/13/20 jk RS chg to Qualified.  1/22/20 jk released per CPTAC SME's review of PRAD Path Review CDE set. 1/8/20 jk created for CPTAC Path Review and Local Path CRFs; applicable to PRAD tumor types.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}